Article
BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
17 Aug 2011
Abstract excerpt
PURPOSE: Despite initial sensitivity to chemotherapy, ovarian cancers (OVCA) often develop drug resistance, which limits patient survival. Using specimens and/or genomic data from 289 patients and a panel of cancer cell lines, we explored genome-wide expression changes that underlie the evolution of OVCA chemoresistance and characterized the BCL2 antagonist of cell death (BAD) apoptosis pathway as a determinant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
